临床研究
Copyright ©The Author(s) 2017.
世界华人消化杂志. 2017-09-18; 25(26): 2360-2365
在线出版 2017-09-18. doi: 10.11569/wcjd.v25.i26.2360
表1 慢性乙型肝炎病毒感染孕妇核苷(酸)类抗病毒治疗前后焦虑和抑郁状态评分 (mean±SD)
SAStPSDStP
治疗前42.23±4.6144.81±4.67
国内常模33.82±5.9718.2280.00441.88±8.976.2730.019
治疗后35.14±5.6019.1260.00238.02±5.2620.8960.000
表2 慢性乙型肝炎病毒感染孕妇抗病毒治疗后焦虑和抑郁状态改善的影响因素
影响因素n治疗前后SAS差值FP治疗前后SDS差值FP
年龄(岁)
<35756.70±3.531.9660.1646.98±3.141.4200.236
≥35258.25±4.036.20±3.56
婚姻状况
初婚72767±3680.7560.3877.08±3.223.2870.073
再婚28558±3396.03±3.26
教育程度
初中以下185.30±1.370.7170.4915.44±1.730.7610.470
高中215.88±2.136.06±3.12
本科以上616.67±3.756.07±2.99
意外妊娠
105.62±2.902.8030.0975.13±0.925.1740.075
907.25±3.766.97±3.36
产次
初产736.87±3.581.0630.3057.05±3.180.0160.899
多产277.68±4.046.06±3.35
不良孕产史
106.99±3.670.4300.5146.69±3.110.1340.715
908.00±4.227.62±4.38
抗病毒药
替比夫定658.82±4.342.1440.1467.75±4.040.0550.815
替诺福韦356.15±2.956.27±2.62
HBV DNA(IU/mL)
<104574.65±2.2213.4390.0004.94±2.206.1960.014
≥104438.93±3.558.18±3.23
表3 慢性乙型肝炎病毒感染孕妇抗病毒治疗后焦虑和抑郁状态改善的logistic回归分析
影响因素焦虑改善[n = 77(77%)]
抑郁改善[n = 81(81%)]
bWaldPOR(95%CI)bWaldPOR(95%CI)
年龄-0.4720.5730.4490.624(0.184-2.115)-0.7541.5630.2110.471(0.144-1.534)
婚姻状况-0.3170.3060.5800.729(0.237-2.237)-0.4260.5430.4610.653(0.210-2.030)
教育程度-0.0660.0270.8690.936(0.428-2.049)-0.2110.2450.6210.809(0.350-1.870)
意外妊娠-0.6880.5970.4400.502(0.088-2.880)0.0030.0000.9981.003(0.179-5.642)
产次-0.4040.4790.4890.668(0.213-2.095)-0.4310.5400.4630.650(0.206-2.052)
不良孕产史0.0380.0020.9671.039(0.172-6.292)0.7000.3900.5322.013(0.224-18.009)
药物0.5610.8070.3691.752(0.515-5.956)0.3820.3890.5331.465(0.441-4.871)
HBV DNA-1.8057.2880.0076.078(1.640-22.534)-1.1983.0580.0463.314(1.265-12.691)

引文著录: 尹迎辉, 王玫. 核苷(酸)类似物对慢性乙肝病毒感染孕妇焦虑和抑郁状态的影响. 世界华人消化杂志 2017; 25(26): 2360-2365